- Home
- SARS-CoV-2 Omicron Spike Antigens
- SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
The Native Antigen
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
- SKU:
- REC32007
- UPC:
- MPN:
Description
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | REC32007 from Native Antigen is available for delivery.
SARS-CoV-2 (B.1.1.529/Omicron) Spike RBD (receptor binding domain) protein. Relative to Wuhan-Hu-1 this protein has following amino acid changes: G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
PRODUCT DETAILS – SARS-COV-2 (B.1.1.529/OMICRON) SPIKE GLYCOPROTEIN (S1) RBD, HIS-TAG (HEK293)
- SARS-CoV-2 (B.1.1.529/Omicron) spike RBD (Accession: GISAID EPI_ISL_6795838)
- SARS-CoV-2 (B.1.1.529/Omicron) RBD contains G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H mutations relative to Wuhan Hu-1.
- Expressed in HEK293 and purified by affinity chromatography.
- Presented as liquid to high purity.
BACKGROUND
South Africa reported the identification of a new SARS-CoV-2 variant, B.1.1.529, to the World Health Organization (WHO) on November 24, 2021. B.1.1.529 was first detected in specimens collected in Botswana and South Africa. On December 1, 2021, the first case attributed to B.1.1.529 was reported in the United States in a person who returned from travel to South Africa. The Omicron variant has since been detected in travel-related cases in an increasing number of European countries, as well as Australia, Brazil, Canada, Hong Kong, Israel, Japan, Nigeria, Norway, Sweden, and the United Kingdom. A few countries, including the United States, have reported cases in individuals without travel history to southern Africa.
On November 26, 2021, the Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) convened to assess B.1.1.529. The TAG-VE advised WHO that this variant should be designated as a Variant of Concern (VOC), and WHO designated B.1.1.529 as a VOC named Omicron. The European Center for Disease Prevention and Control also classified this variant as a VOC due to concerns regarding immune escape and potentially increased transmissibility compared to the Delta variant.
Omicron has a large number of spike protein substitutions, some of which are known from other variants to be associated with reduced susceptibility to available monoclonal antibody therapeutics or reduced neutralization by convalescent and vaccinee sera. The spike protein of the Omicron variant is characterized by at least 30 amino acid substitutions, three small deletions, and one small insertion. Notably, 15 of the 30 amino acid substitutions are in the receptor binding domain (RBD). There are also a number of changes and deletions in other genomic regions. Some diagnostic kits have significantly reduced S-gene target sensitivity due to the deletion at H69 and V70 in the B Omicron spike protein. Specimens being tested using these kits that yield an S gene target failure (SGTF) ‘may’ be Omicron (CDC, 2021).
REFERENCES
- Science Brief: Omicron (B.1.1.529) Variant (CDC).
- Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern (WHO).
- Threat Assessment Brief: Implications of the emergence and spread of the SARS-CoV-2 B.1.1. 529 variant of concern (Omicron) for the EU/EEA (ECDC).
Related Products

Recombinant SARS-CoV-2 S1+S2 Protein (ECD, C-His Tag) (Omicron) | PKSV030471
Elabscience

Recombinant SARS-CoV-2 Spike S1 NTD Protein (ECD, C-His Tag) (Omicron) | PKSV030473
Elabscience

Recombinant SARS-CoV-2 Spike RBD Protein (N-His Tag) (Omicron) | PKSV030475
Elabscience

Recombinant SARS-CoV-2 Spike RBD Protein (C-His Tag) (Omicron) | PKSV030477
Elabscience

Recombinant SARS-CoV-2 Spike S1 Protein (C-His Tag) (Omicron) | PKSV030480
Elabscience

SARS-CoV-2 Spike Glycoprotein-crude (B.1.1.529-Omicron) | S-CP-P2010
Elabscience
Customers Also Viewed


SARS-CoV-2 Nucleocapsid Protein Antibody (HRP) | abx243133
abbexa


SARS-CoV-2 Trimeric Spike 1 Protein Antibody | abx024241
abbexa


SARS-CoV-2 Spike Protein RBD (Alpha B.1.1.7 Variant) | abx620010
abbexa

Anti-SARS-CoV-2 Spike RBD (CB6 biosimilar) Neutralizing Antibody | E-AB-V1028
Elabscience

CleanPlex for MGI SARS-CoV-2 Panel (8) | 918001
BioServUK

TMB Chromogen (in dimethylsulfoxide) (4 ml) | R4-04
BioServUK

TMB Chromogen (in dimethylsulfoxide) (500 ul) | R4-01
BioServUK

Capture Affimer Reagent 1 | BSV-COV-CA01
BioServUK

Elite Anti-SARS-CoV-2 Spike (S2) Monoclonal Antibody, Clone COS2β-2 | BSV-S2-02-0.1mg
BioServUK


COVID-19 Spike Protein Accquant® ELISA Kit
Fine Test

SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), His-Tag (CHO)
The Native Antigen

SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)
The Native Antigen

abm | Partial ORF1ab 12500-13500 Fragment cDNA Control | G633-15
ABM Good

abm | Partial ORF1ab 18500-19500 Fragment RNA Control | G632-17
ABM Good

abm | Partial ORF1ab 12500-13500 Fragment RNA Control | G632-15
ABM Good

abm | ORF1ab 14981 – 15981 Fragment cDNA Control | G633-8
ABM Good

abm | Partial ORF1ab - Partial S Gene 28259 – 29258 Fragment RNA Control | G632-9
ABM Good

abm | Partial ORF7a - ORF8 - Partial N Gene 27744 – 28744 Fragment RNA Control | G632-6
ABM Good

Anti-SARS-CoV-2 Neutralization Antibody Rapid Test Kit | CP04005
UnScience

abm | SARS-CoV-2 N-S Fusion (NX-sp12) Recombinant Protein | COV01010
ABM Good


SARS-CoV-2 S1 RBD Protein | abx160076
abbexa


SARS-CoV-2 S1 Protein | abx160074
abbexa


SARS-CoV-2 Nucleocapsid Protein Antibody | abx243132
abbexa


SARS-CoV-2 Nucleocapsid Protein Antibody | abx229487
abbexa


SARS-CoV-2 Nucleocapsid Protein Antibody | abx024239
abbexa


SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) | abx620012
abbexa


SARS-CoV-2 Spike Protein RBD (B.1.617 Variant) | abx620009
abbexa


SARS-CoV-2 Spike Protein RBD (N450K Mutation) | abx620011
abbexa


SARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant) | abx160085
abbexa


SARS-CoV-2 S1 Protein RBD (Alpha B.1.1.7 Variant) | abx160084
abbexa


SARS-CoV-2 Spike Protein S1 RBD ELISA Kit | abx365031
abbexa


Human SARS-CoV-2 Spike Protein Total Antibody ELISA Kit | abx365085
abbexa


Human SARS-CoV-2 Nucleocapsid Protein IgG ELISA Kit | abx392294
abbexa


Human SARS-CoV-2 Neutralizing Antibody ELISA Kit | abx365044
abbexa


SARS-CoV-2 RT-qPCR Kit | abx460001
abbexa


SARS-CoV-2 Antigen Rapid Test Kit | abx294181
abbexa

SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen B.1.429 Mutation (U.S. California Variant)
Genprice Gentaur

SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen B.1.525 Mutation (UK & Nigeria Variant)
Genprice Gentaur

pPACK-BALD Envelope Protein-free Lentivector Packaging Mix (XL)
SBI System Biosciences

INgezim COVID 19 DR
Eurofins

ELISA Kit for Interferon Beta (IFNb) | SEA222Hu
Cloud-Clone

Recombinant Transmembrane Protease, Serine 2 (TMPRSS2) | RPC795Hu01
Cloud-Clone

Recombinant Monokine Induced By Interferon Gamma (MIg) | RPB928Hu01
Cloud-Clone

Recombinant Interferon Beta (IFNb) | RPA222Hu02
Cloud-Clone

human TNF-α,His tag | E410A13-
EnoGene

anti-human TNF-α sdAb (2B) | E409C20-B10
EnoGene

anti-human TNF-α sdAb (1A) | E409C20-A10
EnoGene

Recombinant Human Novel Coronavirus Nucleoprotein(N) | CSB-YP3325GMYa4
Cusabio

SARS-CoV-2 S Recombinant Antibody, FITC Conjugated | A73674
EpiGentek

SARS-CoV-2 Spike Trimer (K417N, D614G), His Tag (MALS verified) B.1.351 (South Africa) | SPN-C52Hm
Acro Biosystems